News & Updates
Showing Neurology articles
Showing
Show Multimedia Only

Nelonemdaz safe but fails to improve outcomes in stroke
01 Nov 2022
Treatment with nelonemdaz, a multitarget neuroprotectant that selectively blocks N-methyl-D-aspartate receptors and scavenges free radicals, does not appear to significantly improve stroke outcomes as compared with placebo, although nelonemdaz-treated patients show a greater tendency toward achieving modified Rankin Scale scores of 0–2 at 12 weeks, according to the results of a phase II study.
01 Nov 2022

Early noninferior to delayed NOAC initiation after stroke in AF patients
13 Oct 2022
Early initiation of nonvitamin K antagonist oral anticoagulants (NOACs) after acute ischaemic stroke in patients with atrial fibrillation (AF) appears to yield similar outcomes when compared with delayed initiation, as shown in the results of the TIMING* study.
13 Oct 2022






